Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Aker BioMarine ASA ( (DE:1PG) ) has shared an announcement.
Aker BioMarine ASA has received approval from the Financial Supervisory Authority of Norway for the base prospectus related to its latest bond issue, which will be listed on the Oslo Stock Exchange. This approval marks a significant step for the company, potentially enhancing its financial flexibility and market presence.
More about Aker BioMarine ASA
Aker BioMarine is a leading innovator in human health and nutrition, specializing in krill-derived products from Antarctica. Their offerings include Superba Krill Oil, Lysoveta, Revervia, and PL+, along with the consumer brand Kori Krill. The company also ventures into sustainability with AION, focusing on reducing and recycling plastic waste, and Understory, a protein brand. Aker BioMarine is listed on the Oslo Stock Exchange.
YTD Price Performance: -11.77%
Average Trading Volume: 28,613
Current Market Cap: NOK5.19B
Find detailed analytics on 1PG stock on TipRanks’ Stock Analysis page.